Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1529229

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1529229

Asia Pacific Postpartum Depression Drugs Market Size, Share & Trends Analysis Report By Treatment (Pharmacotherapy, Hormonal Therapy, and Others), By Route of Administration, By Distribution Channel, By Type, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Asia Pacific Postpartum Depression Drugs Market would witness market growth of 10.0% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Postpartum Depression Drugs Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $123.9 million by 2031. The Japan market is registering a CAGR of 9.3% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 10.6% during (2024 - 2031).

Postpartum depression medications are frequently combined with other therapeutic approaches to ensure comprehensive care. This includes psychotherapy (such as cognitive-behavioral therapy), support groups, and lifestyle modifications. The combination of pharmacotherapy and psychotherapy has been shown to improve treatment outcomes, reduce symptom severity, and enhance overall well-being for women experiencing postpartum depression.

The adoption of postpartum depression drugs refers to the utilization and acceptance of pharmacological treatments among healthcare providers and patients for managing symptoms of postpartum depression (PPD). Adoption rates can vary significantly based on healthcare access, cultural attitudes toward mental health, and healthcare provider practices. Adoption begins with healthcare providers' awareness and knowledge of postpartum depression as a significant mental health issue. Providers trained in perinatal mental health are more likely to recognize symptoms of PPD and initiate appropriate treatments, including pharmacotherapy.

As China's middle class expands and healthcare access improves, there is a growing demand for specialized healthcare services, including mental health treatments. This demographic shift fuels the market for PPD drugs, prompting pharmaceutical companies to invest in meeting this increasing demand. Chinese pharmaceutical firms often collaborate with international partners to leverage global expertise and technologies in developing PPD drugs. These collaborations facilitate the transfer of knowledge and accelerate the introduction of innovative therapies into the Chinese market. Thus, the increasing pharmaceutical industry is driving the growth of the market.

Based on Treatment, the market is segmented into Pharmacotherapy, Hormonal Therapy, and Others. Based on Route of Administration, the market is segmented into Oral, Parenteral, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on Type, the market is segmented into Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder (OCD), Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder (PTSD), and Postpartum Psychosis. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • Pfizer, Inc.
  • Eli Lilly And Company
  • Novartis AG
  • GlaxoSmithKline PLC (GSK)
  • Merck & Co., Inc.
  • Biogen, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Bausch Health Companies, Inc.(DermTech, Inc.)
  • Cipla Limited
  • Sage Therapeutics, Inc.

Asia Pacific Postpartum Depression Drugs Market Report Segmentation

By Treatment

  • Pharmacotherapy
  • Hormonal Therapy
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Type

  • Postpartum Anxiety
  • Postpartum Blues
  • Postpartum Obsessive-Compulsive Disorder (OCD)
  • Postpartum Panic Disorder
  • Postpartum Post-Traumatic Stress Disorder (PTSD)
  • Postpartum Psychosis

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Postpartum Depression Drugs Market, by Treatment
    • 1.4.2 Asia Pacific Postpartum Depression Drugs Market, by Route of Administration
    • 1.4.3 Asia Pacific Postpartum Depression Drugs Market, by Distribution Channel
    • 1.4.4 Asia Pacific Postpartum Depression Drugs Market, by Type
    • 1.4.5 Asia Pacific Postpartum Depression Drugs Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Postpartum Depression Drugs Market by Treatment

  • 4.1 Asia Pacific Pharmacotherapy Market by Country
  • 4.2 Asia Pacific Hormonal Therapy Market by Country
  • 4.3 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Postpartum Depression Drugs Market by Route of Administration

  • 5.1 Asia Pacific Oral Market by Country
  • 5.2 Asia Pacific Parenteral Market by Country
  • 5.3 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Postpartum Depression Drugs Market by Distribution Channel

  • 6.1 Asia Pacific Hospital Pharmacy Market by Country
  • 6.2 Asia Pacific Retail Pharmacy Market by Country
  • 6.3 Asia Pacific Online Pharmacy Market by Country

Chapter 7. Asia Pacific Postpartum Depression Drugs Market by Type

  • 7.1 Asia Pacific Postpartum Anxiety Market by Country
  • 7.2 Asia Pacific Postpartum Blues Market by Country
  • 7.3 Asia Pacific Postpartum Obsessive-Compulsive Disorder (OCD) Market by Country
  • 7.4 Asia Pacific Postpartum Panic Disorder Market by Country
  • 7.5 Asia Pacific Postpartum Post-Traumatic Stress Disorder (PTSD) Market by Country
  • 7.6 Asia Pacific Postpartum Psychosis Market by Country

Chapter 8. Asia Pacific Postpartum Depression Drugs Market by Country

  • 8.1 China Postpartum Depression Drugs Market
    • 8.1.1 China Postpartum Depression Drugs Market by Treatment
    • 8.1.2 China Postpartum Depression Drugs Market by Route of Administration
    • 8.1.3 China Postpartum Depression Drugs Market by Distribution Channel
    • 8.1.4 China Postpartum Depression Drugs Market by Type
  • 8.2 Japan Postpartum Depression Drugs Market
    • 8.2.1 Japan Postpartum Depression Drugs Market by Treatment
    • 8.2.2 Japan Postpartum Depression Drugs Market by Route of Administration
    • 8.2.3 Japan Postpartum Depression Drugs Market by Distribution Channel
    • 8.2.4 Japan Postpartum Depression Drugs Market by Type
  • 8.3 India Postpartum Depression Drugs Market
    • 8.3.1 India Postpartum Depression Drugs Market by Treatment
    • 8.3.2 India Postpartum Depression Drugs Market by Route of Administration
    • 8.3.3 India Postpartum Depression Drugs Market by Distribution Channel
    • 8.3.4 India Postpartum Depression Drugs Market by Type
  • 8.4 South Korea Postpartum Depression Drugs Market
    • 8.4.1 South Korea Postpartum Depression Drugs Market by Treatment
    • 8.4.2 South Korea Postpartum Depression Drugs Market by Route of Administration
    • 8.4.3 South Korea Postpartum Depression Drugs Market by Distribution Channel
    • 8.4.4 South Korea Postpartum Depression Drugs Market by Type
  • 8.5 Singapore Postpartum Depression Drugs Market
    • 8.5.1 Singapore Postpartum Depression Drugs Market by Treatment
    • 8.5.2 Singapore Postpartum Depression Drugs Market by Route of Administration
    • 8.5.3 Singapore Postpartum Depression Drugs Market by Distribution Channel
    • 8.5.4 Singapore Postpartum Depression Drugs Market by Type
  • 8.6 Malaysia Postpartum Depression Drugs Market
    • 8.6.1 Malaysia Postpartum Depression Drugs Market by Treatment
    • 8.6.2 Malaysia Postpartum Depression Drugs Market by Route of Administration
    • 8.6.3 Malaysia Postpartum Depression Drugs Market by Distribution Channel
    • 8.6.4 Malaysia Postpartum Depression Drugs Market by Type
  • 8.7 Rest of Asia Pacific Postpartum Depression Drugs Market
    • 8.7.1 Rest of Asia Pacific Postpartum Depression Drugs Market by Treatment
    • 8.7.2 Rest of Asia Pacific Postpartum Depression Drugs Market by Route of Administration
    • 8.7.3 Rest of Asia Pacific Postpartum Depression Drugs Market by Distribution Channel
    • 8.7.4 Rest of Asia Pacific Postpartum Depression Drugs Market by Type

Chapter 9. Company Profiles

  • 9.1 Pfizer, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Regional & Segmental Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 SWOT Analysis
  • 9.2 Eli Lilly And Company
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 SWOT Analysis
  • 9.3 Novartis AG
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 SWOT Analysis
  • 9.4 GlaxoSmithKline PLC (GSK)
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 SWOT Analysis
  • 9.5 Merck & Co., Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expenses
    • 9.5.5 SWOT Analysis
  • 9.6 Biogen, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Trails and Approvals:
    • 9.6.6 SWOT Analysis
  • 9.7 Teva Pharmaceutical Industries Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 SWOT Analysis
  • 9.8 Bausch Health Companies, Inc. (DermTech, Inc.)
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expense
    • 9.8.5 SWOT Analysis
  • 9.9 Cipla Limited
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 SWOT Analysis
  • 9.10. Sage Therapeutics, Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 Asia Pacific Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 2 Asia Pacific Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 3 Asia Pacific Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 4 Asia Pacific Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 5 Asia Pacific Pharmacotherapy Market by Country, 2020 - 2023, USD Million
  • TABLE 6 Asia Pacific Pharmacotherapy Market by Country, 2024 - 2031, USD Million
  • TABLE 7 Asia Pacific Hormonal Therapy Market by Country, 2020 - 2023, USD Million
  • TABLE 8 Asia Pacific Hormonal Therapy Market by Country, 2024 - 2031, USD Million
  • TABLE 9 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
  • TABLE 10 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
  • TABLE 11 Asia Pacific Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 12 Asia Pacific Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 13 Asia Pacific Oral Market by Country, 2020 - 2023, USD Million
  • TABLE 14 Asia Pacific Oral Market by Country, 2024 - 2031, USD Million
  • TABLE 15 Asia Pacific Parenteral Market by Country, 2020 - 2023, USD Million
  • TABLE 16 Asia Pacific Parenteral Market by Country, 2024 - 2031, USD Million
  • TABLE 17 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
  • TABLE 18 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
  • TABLE 19 Asia Pacific Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 20 Asia Pacific Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 21 Asia Pacific Hospital Pharmacy Market by Country, 2020 - 2023, USD Million
  • TABLE 22 Asia Pacific Hospital Pharmacy Market by Country, 2024 - 2031, USD Million
  • TABLE 23 Asia Pacific Retail Pharmacy Market by Country, 2020 - 2023, USD Million
  • TABLE 24 Asia Pacific Retail Pharmacy Market by Country, 2024 - 2031, USD Million
  • TABLE 25 Asia Pacific Online Pharmacy Market by Country, 2020 - 2023, USD Million
  • TABLE 26 Asia Pacific Online Pharmacy Market by Country, 2024 - 2031, USD Million
  • TABLE 27 Asia Pacific Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 28 Asia Pacific Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 29 Asia Pacific Postpartum Anxiety Market by Country, 2020 - 2023, USD Million
  • TABLE 30 Asia Pacific Postpartum Anxiety Market by Country, 2024 - 2031, USD Million
  • TABLE 31 Asia Pacific Postpartum Blues Market by Country, 2020 - 2023, USD Million
  • TABLE 32 Asia Pacific Postpartum Blues Market by Country, 2024 - 2031, USD Million
  • TABLE 33 Asia Pacific Postpartum Obsessive-Compulsive Disorder (OCD) Market by Country, 2020 - 2023, USD Million
  • TABLE 34 Asia Pacific Postpartum Obsessive-Compulsive Disorder (OCD) Market by Country, 2024 - 2031, USD Million
  • TABLE 35 Asia Pacific Postpartum Panic Disorder Market by Country, 2020 - 2023, USD Million
  • TABLE 36 Asia Pacific Postpartum Panic Disorder Market by Country, 2024 - 2031, USD Million
  • TABLE 37 Asia Pacific Postpartum Post-Traumatic Stress Disorder (PTSD) Market by Country, 2020 - 2023, USD Million
  • TABLE 38 Asia Pacific Postpartum Post-Traumatic Stress Disorder (PTSD) Market by Country, 2024 - 2031, USD Million
  • TABLE 39 Asia Pacific Postpartum Psychosis Market by Country, 2020 - 2023, USD Million
  • TABLE 40 Asia Pacific Postpartum Psychosis Market by Country, 2024 - 2031, USD Million
  • TABLE 41 Asia Pacific Postpartum Depression Drugs Market by Country, 2020 - 2023, USD Million
  • TABLE 42 Asia Pacific Postpartum Depression Drugs Market by Country, 2024 - 2031, USD Million
  • TABLE 43 China Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 44 China Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 45 China Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 46 China Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 47 China Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 48 China Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 49 China Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 50 China Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 51 China Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 52 China Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 53 Japan Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 54 Japan Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 55 Japan Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 56 Japan Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 57 Japan Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 58 Japan Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 59 Japan Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 60 Japan Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 61 Japan Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 62 Japan Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 63 India Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 64 India Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 65 India Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 66 India Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 67 India Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 68 India Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 69 India Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 70 India Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 71 India Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 72 India Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 73 South Korea Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 74 South Korea Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 75 South Korea Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 76 South Korea Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 77 South Korea Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 78 South Korea Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 79 South Korea Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 80 South Korea Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 81 South Korea Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 82 South Korea Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 83 Singapore Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 84 Singapore Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 85 Singapore Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 86 Singapore Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 87 Singapore Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 88 Singapore Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 89 Singapore Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 90 Singapore Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 91 Singapore Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 92 Singapore Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 93 Malaysia Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 94 Malaysia Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 95 Malaysia Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 96 Malaysia Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 97 Malaysia Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 98 Malaysia Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 99 Malaysia Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 100 Malaysia Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 101 Malaysia Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 102 Malaysia Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 103 Rest of Asia Pacific Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 104 Rest of Asia Pacific Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 105 Rest of Asia Pacific Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 106 Rest of Asia Pacific Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 107 Rest of Asia Pacific Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 108 Rest of Asia Pacific Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 109 Rest of Asia Pacific Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 110 Rest of Asia Pacific Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 111 Rest of Asia Pacific Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 112 Rest of Asia Pacific Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 113 Key Information - Pfizer, Inc.
  • TABLE 114 Key Information - Eli Lilly And Company
  • TABLE 115 Key Information - Novartis AG
  • TABLE 116 Key Information - GlaxoSmithKline PLC
  • TABLE 117 Key Information - Merck & Co., Inc.
  • TABLE 118 Key Information - Biogen, Inc.
  • TABLE 119 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 120 key information - Bausch Health Companies, Inc.
  • TABLE 121 Key Information - Cipla Limited
  • TABLE 122 Key Information - Sage Therapeutics, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!